<DOC>
	<DOCNO>NCT01709279</DOCNO>
	<brief_summary>Mesenchymal stem cell capability differentiate myocardium , vascular endothelial cell , vascular smooth muscle cell useful heart regeneration . Adipose tissue relatively enrich mesenchymal stem cell compare bone marrow tissue . In trial , eligible ischemic heart failure patient proceed intracoronary administration autologous adipose tissue derive stromal cell cardiac catheterization .</brief_summary>
	<brief_title>Clinical Trial Autologous Adipose Tissue Derived Stromal Cell Therapy Ischemic Heart Failure</brief_title>
	<detailed_description>The population ischemic heart failure patient enormous Japan radical treatment heart transplantation : however , number give donor extremely limited . Mesenchymal stem cell capable differentiate mesodermal-lineage cell well endodermal-lineage cell myocardial cell . They reside mesenchymal tissue bone marrows well adipose tissue . The latter tissue relatively enrich mesenchymal stem cell compare bone marrow cell . In study , ischemic heart failure patient undergo intracoronary administration autologous adipose tissue derive stromal cell cardiac catheterization .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<criteria>Heart failure patient occur prior ischemic event whose ejection fraction must less 40 % . Complicated severe organ disease . Patient malignancy . History chemotherapy irradiation within 4 week . Patient immunodeficiency Pregnancy possibility pregnancy Candidate judge applicable study doctor .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Ischemic heart failure</keyword>
	<keyword>Myocardial regeneration</keyword>
	<keyword>ADRC</keyword>
</DOC>